Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2017 | Involving patients in clinical trial design: a message to academia and industry

Jan Geissler • 24 Jun 2017
EHA 2017
Chronic Myeloid Leukemia General

Jan Geissler from CML Advocates Network calls out to academia and industry to create and implement structured operating procedures so that patient values and patient-centric outcomes are part of initial clinical trial design. This video was recorded at the European Society of Hematology congress in Madrid, Spain.

More from Jan Geissler

The need for patient advocates to attend major congresses such as EBMT
1:21
The need for patient advocates to attend major congresses such as EBMT
Jan Geissler • 24 Mar 2019
The evolution of patient advocacy
1:14
The evolution of patient advocacy
Jan Geissler • 24 Mar 2019
The importance of patient advocacy tracks at congresses
1:28
The importance of patient advocacy tracks at congresses
Jan Geissler • 24 Mar 2019
The aims of the Patvocates Network
0:53
The aims of the Patvocates Network
Jan Geissler • 24 Mar 2019

Related Videos

Key principles for implementing AI tools into clinical practice
3:19
Key principles for implementing AI tools into clinical practice
Adrián Mosquera Orgueira • 24 Sep 2026
Current role of AI in hematology/oncology: separating the hype from reality
2:54
Current role of AI in hematology/oncology: separating the hype from reality
Adrián Mosquera Orgueira • 24 Sep 2026
Addressing the risk of over-reliance on AI in clinical decision-making
2:25
Addressing the risk of over-reliance on AI in clinical decision-making
Adrián Mosquera Orgueira • 24 Sep 2026
Telomere dynamics in normal and pathological aging
12:41
Telomere dynamics in normal and pathological aging
Coleman Lindsley • 18 Sep 2026
The content of VJHemOnc is intended for healthcare professionals